Free Trial
LON:ROQ

Roquefort Therapeutics (ROQ) Share Price, News & Analysis

Roquefort Therapeutics logo
GBX 1.40 -0.15 (-9.48%)
As of 07/15/2025 06:14 AM Eastern

About Roquefort Therapeutics Stock (LON:ROQ)

Key Stats

Today's Range
1.40
1.55
50-Day Range
1.33
2
52-Week Range
1.08
6.78
Volume
270,000 shs
Average Volume
2.07 million shs
Market Capitalization
£1.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ROQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ROQ Stock News Headlines

3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.
Roquefort Thera Share Chat (ROQ)
See More Headlines

ROQ Stock Analysis - Frequently Asked Questions

Roquefort Therapeutics' stock was trading at GBX 4.10 at the beginning of 2025. Since then, ROQ shares have decreased by 65.8% and is now trading at GBX 1.40.

Roquefort Therapeutics plc (LON:ROQ) announced its quarterly earnings results on Wednesday, April, 30th. The company reported ($0.75) earnings per share for the quarter. Roquefort Therapeutics had a negative net margin of 57,057.07% and a negative trailing twelve-month return on equity of 29.57%.

Shares of ROQ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Roquefort Therapeutics investors own include Vislink Technologies (XGTI), AutoZone (AZO), Intel (INTC), Premier African Minerals (PREM), Rolls-Royce Holdings plc (RR), TJX Companies (TJX) and Abacus Health Products (ABAHF).

Company Calendar

Last Earnings
4/30/2025
Today
7/15/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:ROQ
CIK
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (1.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£1.52 million
Net Margins
-57,057.07%
Pretax Margin
N/A
Return on Equity
-29.57%
Return on Assets
-15.86%

Debt

Debt-to-Equity Ratio
12.37
Current Ratio
0.79
Quick Ratio
3.07

Sales & Book Value

Annual Sales
£2.66 thousand
Price / Sales
670.60
Cash Flow
GBX 0.94 per share
Price / Cash Flow
1.49
Book Value
GBX 3.82 per share
Price / Book
0.37

Miscellaneous

Outstanding Shares
127,254,864
Free Float
N/A
Market Cap
£1.79 million
Optionable
Not Optionable
Beta
0.05
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (LON:ROQ) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners